CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
16676-29-2 | 盐酸纳曲酮; 17-环丙基甲基-4,5-环氧-3,14-二羟基吗啡喃-6-酮盐酸盐 | Naltrexone hydrochloride; (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride | C20H23NO4.HCl | 详情 | 供应商 | |
95266-40-3 | 抗倒酯; 4-环丙基(羟基)亚甲基-3,5-二酮环己烷羧酸乙酯 | Trinexapac-ethyl; 4-(Cyclopropyl-alpha-hydroxymethylene)-3,5-dioxo-cyclohexanecarboxylic acid ethyl ester; Ethyl 4-cyclopropyl(hydroxy)methylene-3,5-dioxocyclohexanecarboxylate | C13H16O5 | 详情 | 供应商 | |
147511-69-1 | 匹伐他汀; (3R,5S,6E)-7-(2-环丙基-4-(4-氟苯基)喹啉-3-基)-3,5-二羟基庚-6-烯酸 | Pitavastatin; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid | C25H24FNO4 | 详情 | 供应商 | |
147526-32-7 | 匹伐他汀钙; (+)-双{(3R,5S,6E)-7-[2-环丙基-4-(4-氟代苯基)喹啉-3-基]-3,5-二羟基-6-庚烯酸}钙盐(2:1) | Pitavastatin calcium; :(+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate} | C50H46CaF2N2O8 | 详情 | 供应商 | |
148901-69-3 | (E)-7-[2-环丙基-4-(4-氟苯基)-3-喹啉基]-5-羟基-3-氧代-6-庚烯酸乙酯 | Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate; (E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl ester | C27H26FNO4 | 详情 | 供应商 | |
172336-32-2 | (E)-3,5-二羟基-7-[2-环丙基-4-(4-氟苯基)-3-喹啉基]庚-6-烯酸乙酯 | Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate; (3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester | C27H28FNO4 | 详情 | 供应商 | |
951163-60-3 | 7-[(3S,5S)-3-氨基-5-甲基-1-哌啶基]-1-环丙基-1,4-二氢-8-甲氧基-4-氧代-3-喹啉甲酸 2-羟基丁二酸 | Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-di; Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylicacid; 7-[(3S,5S)-3-Amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid with 2-hydroxybutanedioic acid | C20H25N3O4.C4H6O5 | 详情 | 供应商 | |
72786-10-8 | (E)-4-[[(5Α,6Β)-17-(环丙基甲基)-4,5-环氧-3,14-二羟基吗啡-6-基]氨基]-4-氧-2-丁烯酸甲酯盐酸盐 | BETA-FUNALTREXAMINE HYDROCHLORIDE; (E)-[4-[[(5A,6B)-17-CYCLOPROPYLMETHYL]-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOICACID METHYL ESTER HYDROCHLORIDE; (E)-4-[[(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOIC ACID METHYL ESTER HYDROCHLORIDE; BETA-FUNALTREXAMINE; BETA-FUNALTREXAMINE HYDROCHLORIDE; BETA-FNA HYDROCHLORIDE; B-FUNALTREXAMINE HYDROCHLORIDE (B-FNA) S PECIFIC NON-EQUILIBR; BETA-FUNALTREXAMINE HCL; (E)-4-((5a,6b)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)amino)-4-oxo-2-butenoicacidmethylesterhyd | C25H32ClN2O6 | 详情 | 供应商 | |
254452-86-3 | (3S,5R,6E)-7-[2-环丙基-4-(4-氟苯基)-3-喹啉基]-3,5-二羟基-6-庚烯酸; (3S,5R,6E)-7-[2-环丙基-4-(4-氟苯基 | (3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid | C25H24FNO4 | 详情 | 供应商 | |
5617-87-8 | 3-环丙基-3-羟基丙酸 | 3-CYCLOPROPYL-3-HYDROXYPROPANOIC ACID | 无 | 详情 | 供应商 | |
147511-70-4 | (3R,5S)-7-[2-环丙基-4-(4-氟苯基)-3-喹啉-基]-3,5-二羟基-6-庚酸(+)苯乙胺; (3R,5S)-7-[2-环丙基-4-(4-氟苯基)-3-喹啉-基]-3,5-二羟基-6-庚酸(+)苯乙胺; (3R,5S)-7-[2-环丙基-4-(4-氟苯基)-3-喹啉基]-3,5-二羟基-6-庚烯酸 (+)-苯乙胺盐 | (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid,; (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid,; (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid (+)-phenylethylamine salt; (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptaneacid,(+)phenylethylamine; 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl] -3,5-dihy -droxy-, (3R,5S,6E)-, coMpd. with (R)-MethylbenzeneMethanaMine (1:1) | C25H24FNO4.C8H11N | 详情 | 供应商 | |
25934-52-5 | 3-环丙基甲氧基-4-羟基苯甲醛; 3-环丙基甲氧基-4-羟基苯甲醛; 罗氟司特中间体3 | 3-CyclopropylMethoxy-4-Hydroxybenzaldehyde | 无 | 详情 | 供应商 | |
63463-44-5 | N-环丙基甲基-4-羟基哌啶 | 1-(cyclopropylmethyl)piperidin-4-ol | 无 | 详情 | 供应商 | |
851847-62-6 | N-环丙基-4-羟基哌啶 | 1-cyclopropyl-4-Piperidinol | 无 | 详情 | 供应商 | |
691852-58-1 | 5-环丙基-2-(4-氟苯基)-6-[(2-羟基乙基)(甲基磺酰基)氨基]-N-甲基-3-苯并呋喃甲酰胺; 5-环丙基-2-(4-氟苯基)-6-[(2-羟基乙基)(甲基磺酰基)氨基]-N-甲基-3-苯并呋喃甲酰胺 | 5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofurancarboxamide; 5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofurancarboxamide; HCV 796; Nesbuvir; nesbuvir = HCV-796 | C22H23FN2O5S | 详情 | 供应商 | |
21573-08-0 | 2-氨基-4-羟基-6-环丙基嘧啶 | 2-amino-6-cyclopropylpyrimidin-4-ol | 无 | 详情 | 供应商 | |
796848-79-8 | N-(2-氯-4-羟基苯基)-N-环丙基-脲 | N-(2-Chloro-4-hydroxyphenyl)-N-cyclopropyl-urea | 无 | 详情 | 供应商 |